Literature DB >> 7504602

Circulating adhesion molecules in tuberculosis.

C K Lai1, K C Wong, C H Chan, S S Ho, S Y Chung, D O Haskard, K N Lai.   

Abstract

Leucocyte-endothelial adhesion molecules have been implicated in the pathogenesis of inflammatory diseases. To evaluate their role as markers of disease activity in tuberculosis, we have used an antigen capture ELISA to measure the serum concentrations of circulating intercellular adhesion molecule-1 (cICAM-1), E-selectin (cE-selectin) and vascular cell adhesion molecule-1 (cVCAM-1) in 34 patients with active tuberculosis (27 with pulmonary disease and seven with lymph node disease) before the commencement of standard chemotherapy, 15 subjects who had previously completed treatment for pulmonary tuberculosis, and 27 healthy volunteers. Circulating ICAM-1 and E-selectin levels were significantly elevated in patients with active tuberculosis when compared to those with treated disease (P < or = 0.01), and healthy controls (P < 0.02). Circulating VCAM-1 was raised in patients with active or old pulmonary tuberculosis (P < 0.02 versus healthy controls) but not in those with tuberculous lymphadenitis. Significant correlations were observed between the levels of cICAM-1 and cE-selectin (p = 0.63, P = 0.0001), and between cICAM-1 and cVCAM-1 (p = 0.28, P = 0.016). Taking the mean +2 s.d. of the serum level in healthy controls as the upper limit of normal range, circulating ICAM-1 had the best discriminative power in identifying active tuberculosis, being elevated in about 80% of patients but was raised in only 6.7% of subjects with treated disease and in 3.7% of normal subjects. Our data support the possibility that three adhesion molecules may be involved in the pathogenesis of tuberculosis and cICAM-1 may be a useful marker of disease activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504602      PMCID: PMC1534426     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  35 in total

1.  Human TH1 and TH2 subsets: doubt no more.

Authors:  S Romagnani
Journal:  Immunol Today       Date:  1991-08

Review 2.  Adhesion molecules and their role in inflammation.

Authors:  S Montefort; S T Holgate
Journal:  Respir Med       Date:  1991-03       Impact factor: 3.415

3.  Radiology in epidemiological studies and some therapeutic trials.

Authors:  G Simon
Journal:  Br Med J       Date:  1966-08-27

4.  A form of circulating ICAM-1 in human serum.

Authors:  R Rothlein; E A Mainolfi; M Czajkowski; S D Marlin
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

5.  Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders.

Authors:  R Seth; F D Raymond; M W Makgoba
Journal:  Lancet       Date:  1991-07-13       Impact factor: 79.321

6.  Antibodies against human neutrophil LECAM-1 (LAM-1/Leu-8/DREG-56 antigen) and endothelial cell ELAM-1 inhibit a common CD18-independent adhesion pathway in vitro.

Authors:  T K Kishimoto; R A Warnock; M A Jutila; E C Butcher; C Lane; D C Anderson; C W Smith
Journal:  Blood       Date:  1991-08-01       Impact factor: 22.113

7.  Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins.

Authors:  M B Lawrence; T A Springer
Journal:  Cell       Date:  1991-05-31       Impact factor: 41.582

8.  Detection of circulating intercellular adhesion molecule-1 antigen in malignant diseases.

Authors:  M Tsujisaki; K Imai; H Hirata; Y Hanzawa; J Masuya; T Nakano; T Sugiyama; M Matsui; Y Hinoda; A Yachi
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

9.  T lymphocyte activation in patients with active tuberculosis.

Authors:  C H Chan; K N Lai; J C Leung; C K Lai
Journal:  Am Rev Respir Dis       Date:  1991-08

10.  Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production.

Authors:  G F Del Prete; M De Carli; C Mastromauro; R Biagiotti; D Macchia; P Falagiani; M Ricci; S Romagnani
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

View more
  6 in total

1.  Biomarkers of endothelial activation/dysfunction distinguish sub-groups of Ugandan patients with sepsis and differing mortality risks.

Authors:  Danielle V Clark; Patrick Banura; Karen Bandeen-Roche; W Conrad Liles; Kevin C Kain; W Michael Scheld; William J Moss; Shevin T Jacob
Journal:  JCI Insight       Date:  2019-04-23

2.  Elevation of serum soluble vascular cell adhesion molecule-1 (sVCAM-1) levels in bronchial asthma.

Authors:  A Koizumi; S Hashimoto; T Kobayashi; K Imai; A Yachi; T Horie
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

3.  Correlates of Vaccine-Induced Protection against Mycobacterium tuberculosis Revealed in Comparative Analyses of Lymphocyte Populations.

Authors:  Sherry L Kurtz; Karen L Elkins
Journal:  Clin Vaccine Immunol       Date:  2015-08-12

4.  Altered expression of CD11/CD18 on the peripheral blood phagocytes of patients with tuberculosis.

Authors:  R J Yassin; A S Hamblin
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

5.  Circulating intercellular adhesion molecules in blood and bronchoalveolar lavage in Behçet's disease.

Authors:  A Hamzaoui; K Hamzaoui; A Chabbou; K Ayed
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711

6.  Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin in patients with tuberculous pleuritis.

Authors:  A Hamzaoui; K Hamzaoui; A Kahan; A Chabbou
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.